Ms. Yarno has served as a member of GBT’s board of directors since December 2017. She has more than 25 years of experience in the biopharmaceutical industry, most recently as the chief marketing officer at HemoShear. Prior to that, she worked at Merck & Co., where she held positions of increasing seniority, most recently as chief marketing officer. In that position, she led a global organization charged with all aspects of supporting pre- and post-launch commercialization of pharmaceuticals in more than 20 therapeutic areas. She also served as general manager for Merck’s Cardiovascular/Metabolic U.S. Business Unit, and as Merck’s senior vice president of human resources. Earlier in her career, she was vice president of the Women’s Health Care franchise for Johnson & Johnson’s Ortho-McNeil Pharmaceutical subsidiary. Ms. Yarno currently serves as a member of the board of directors of Ideaya Biosciences, Inovio Pharmaceuticals and Taurus Pharmaceuticals. She previously served as a member of the boards of several other public and private biotechnology and medical device companies, including Alder BioPharmaceuticals, Aratana Therapeutics, and MyoKardia. Ms. Yarno received a B.S. in business administration from Portland State University and an M.B.A. from Temple University, Fox School of Business.